''INHIBITION OF CD200R1 EXPRESSION BY C/EBP BETA IN REACTIVE MICROGLIAL CELLS.''
Our research line is made of three sublines, specialized in the investigation of brain pathologies, including cerebrovascular diseases, neurodegenerative diseases, and brain ageing.